Compared with patients who responded to the therapy with either partial or complete tumor regression, those with tumors showing no regression in tumor size following chemotherapy had numerous cytoplasmic RPB1-aggregated foci in their first biopsy samples. This evidence concerns the gene POLR2A and neoplasm.